These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 37302524)
1. A natural chalcone cardamonin inhibits necroptosis and ameliorates dextran sulfate sodium (DSS)-induced colitis by targeting RIPK1/3 kinases. Shen X; Chen H; Wen T; Liu L; Yang Y; Xie F; Wang L Eur J Pharmacol; 2023 Sep; 954():175840. PubMed ID: 37302524 [TBL] [Abstract][Full Text] [Related]
2. A novel gut-restricted RIPK1 inhibitor, SZ-15, ameliorates DSS-induced ulcerative colitis. Zeng YS; Peng J; Gao XF; Tian D; Zhan W; Liu J; Hu XJ; Huang S; Tian ST; Qiu L; Liang AL; Wang FY; Dong RH; Guang B; Yang T Eur J Pharmacol; 2022 Dec; 937():175381. PubMed ID: 36368417 [TBL] [Abstract][Full Text] [Related]
3. A pan-RAF inhibitor LY3009120 inhibits necroptosis by preventing phosphorylation of RIPK1 and alleviates dextran sulfate sodium-induced colitis. Zhang C; Luo Y; He Q; Liu S; He A; Yan J Clin Sci (Lond); 2019 Apr; 133(8):919-932. PubMed ID: 30944150 [TBL] [Abstract][Full Text] [Related]
4. Hesperetin ameliorates DSS-induced colitis by maintaining the epithelial barrier via blocking RIPK3/MLKL necroptosis signaling. Zhang J; Lei H; Hu X; Dong W Eur J Pharmacol; 2020 Apr; 873():172992. PubMed ID: 32035144 [TBL] [Abstract][Full Text] [Related]
5. RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury. Newton K; Dugger DL; Maltzman A; Greve JM; Hedehus M; Martin-McNulty B; Carano RA; Cao TC; van Bruggen N; Bernstein L; Lee WP; Wu X; DeVoss J; Zhang J; Jeet S; Peng I; McKenzie BS; Roose-Girma M; Caplazi P; Diehl L; Webster JD; Vucic D Cell Death Differ; 2016 Sep; 23(9):1565-76. PubMed ID: 27177019 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of HtrA2 alleviated dextran sulfate sodium (DSS)-induced colitis by preventing necroptosis of intestinal epithelial cells. Zhang C; He A; Liu S; He Q; Luo Y; He Z; Chen Y; Tao A; Yan J Cell Death Dis; 2019 Apr; 10(5):344. PubMed ID: 31019191 [TBL] [Abstract][Full Text] [Related]
7. ABIN1 Inhibits Inflammation through Necroptosis-Dependent Pathway in Ulcerative Colitis. Bao J; Ye B; Ren Y Genet Res (Camb); 2022; 2022():9313559. PubMed ID: 36034412 [TBL] [Abstract][Full Text] [Related]
8. The Bcr-Abl inhibitor GNF-7 inhibits necroptosis and ameliorates acute kidney injury by targeting RIPK1 and RIPK3 kinases. Qin X; Hu L; Shi SN; Chen X; Zhuang C; Zhang W; Jitkaew S; Pang X; Yu J; Tan YX; Wang HY; Cai Z Biochem Pharmacol; 2020 Jul; 177():113947. PubMed ID: 32247850 [TBL] [Abstract][Full Text] [Related]
9. Dihydrotanshinone I, a natural product, ameliorates DSS-induced experimental ulcerative colitis in mice. Guo Y; Wu X; Wu Q; Lu Y; Shi J; Chen X Toxicol Appl Pharmacol; 2018 Apr; 344():35-45. PubMed ID: 29496522 [TBL] [Abstract][Full Text] [Related]
10. Celastrol inhibits necroptosis by attenuating the RIPK1/RIPK3/MLKL pathway and confers protection against acute pancreatitis in mice. Liang QQ; Shi ZJ; Yuan T; Chen SY; Li YP; Zhang HR; You YP; Xu R; Xu LH; Hu B; Ouyang DY; Zha QB; He XH Int Immunopharmacol; 2023 Apr; 117():109974. PubMed ID: 37012867 [TBL] [Abstract][Full Text] [Related]
11. The anti-inflammatory effect and potential mechanism of cardamonin in DSS-induced colitis. Ren G; Sun A; Deng C; Zhang J; Wu X; Wei X; Mani S; Dou W; Wang Z Am J Physiol Gastrointest Liver Physiol; 2015 Oct; 309(7):G517-27. PubMed ID: 26251468 [TBL] [Abstract][Full Text] [Related]
12. Geniposide ameliorates dextran sulfate sodium-induced ulcerative colitis via KEAP1-Nrf2 signaling pathway. Zhuge X; Jin X; Ji T; Li R; Xue L; Yu W; Quan Z; Tong H; Xu F J Ethnopharmacol; 2023 Oct; 314():116626. PubMed ID: 37187359 [TBL] [Abstract][Full Text] [Related]
13. The Bcr-Abl inhibitor DCC-2036 inhibits necroptosis and ameliorates osteoarthritis by targeting RIPK1 and RIPK3 kinases. Piao L; Wu D; Rui C; Yang Y; Liu S; Liu J; Jin Z; Zhang H; Feng X; Bai L Biomed Pharmacother; 2023 May; 161():114528. PubMed ID: 36931029 [TBL] [Abstract][Full Text] [Related]
15. Dimethyl fumarate inhibits necroptosis and alleviates systemic inflammatory response syndrome by blocking the RIPK1-RIPK3-MLKL axis. Shi FL; Yuan LS; Wong TS; Li Q; Li YP; Xu R; You YP; Yuan T; Zhang HR; Shi ZJ; Zha QB; Hu B; He XH; Ouyang DY Pharmacol Res; 2023 Mar; 189():106697. PubMed ID: 36796462 [TBL] [Abstract][Full Text] [Related]
16. Luteolin ameliorates necroptosis in Glucocorticoid-induced osteonecrosis of the femoral head via RIPK1/RIPK3/MLKL pathway based on network pharmacology analysis. Xu X; Fan X; Wu X; Xia R; Liang J; Gao F; Shu J; Yang M; Sun W Biochem Biophys Res Commun; 2023 Jun; 661():108-118. PubMed ID: 37099894 [TBL] [Abstract][Full Text] [Related]
17. CAMK2/CaMKII activates MLKL in short-term starvation to facilitate autophagic flux. Zhan Q; Jeon J; Li Y; Huang Y; Xiong J; Wang Q; Xu TL; Li Y; Ji FH; Du G; Zhu MX Autophagy; 2022 Apr; 18(4):726-744. PubMed ID: 34282994 [TBL] [Abstract][Full Text] [Related]
18. HuanglianGanjiang Tang alleviates DSS-induced colitis in mice by inhibiting necroptosis through vitamin D receptor. Xiong X; Cheng Z; Zhou Y; Wu F; Xie L; Lawless L; Dong R; Zhao Y; Yu L; Chen G J Ethnopharmacol; 2022 Nov; 298():115655. PubMed ID: 35988837 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of Neural Stem Cell Necroptosis Mediated by RIPK1/MLKL Promotes Functional Recovery After SCI. Tong K; Li S; Chen G; Ma C; Liu X; Liu S; Chen N Mol Neurobiol; 2023 Apr; 60(4):2135-2149. PubMed ID: 36602703 [TBL] [Abstract][Full Text] [Related]
20. Phosphoproteomics Reveals Novel Insights into the Pathogenesis and Identifies New Therapeutic Kinase Targets of Ulcerative Colitis. Tao S; Long X; Gong P; Yu X; Tian L Inflamm Bowel Dis; 2024 Aug; 30(8):1367-1378. PubMed ID: 38085663 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]